Optimize Financial Inc

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 2033266 LAGUNA HILLS, CA

Position in AMLX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$444,813

New position

Shares Held

32,001

first reported quarter

Ownership

0.029%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Optimize Financial Inc holds $2,332,096 across 5 Drug Manufacturers - Specialty & Generic names. AMLX ranks #4 (19.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	927	$549,692
2	LNTH	Lantheus Holdings, Inc.	6,108	$463,291
3	NBIX	Neurocrine Biosciences Inc	3,459	$455,688
4	AMLX	Amylyx Pharmaceuticals, Inc. This page	32,001	$444,813
5	INDV	Indivior Pharmaceuticals, Inc.	13,734	$418,612

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$444,813	32,001	—	Shares	Sole	2026-05-12
No filing history on record for this holder in this stock.